Justin Belcher, MD, PhD
Assistant Professor
Research & Publications
Biography
News
Research Summary
My primary research interest lies with acute kidney injury and novel biomarkers of structural renal damage. More specifically I am interested in acute kidney injury in the setting of cirrhosis and utilizing novel biomarkers to enhance differential diagnosis and guide treatments.
Coauthors
Selected Publications
- Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring.Rauniyar N, Yu X, Cantley J, Voss EZ, Belcher J, Colangelo CM, Stone KL, Dahl N, Parikh C, Lam TT, Cantley LG. Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring. Proteomics. Clinical Applications 2018, 12: e1700157. PMID: 29573172, PMCID: PMC6736530, DOI: 10.1002/prca.201700157.
- Use of a Targeted Urine Proteome Assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant.Williams KR, Colangelo CM, Hou L, Chung L, Belcher JM, Abbott T, Hall IE, Zhao H, Cantley LG, Parikh CR. Use of a Targeted Urine Proteome Assay (TUPA) to identify protein biomarkers of delayed recovery after kidney transplant. Proteomics. Clinical Applications 2017, 11 PMID: 28261998, PMCID: PMC5549272, DOI: 10.1002/prca.201600132.
- Targeting Access to Kidney Care Via Telehealth: The VA Experience.Crowley ST, Belcher J, Choudhury D, Griffin C, Pichler R, Robey B, Rohatgi R, Mielcarek B. Targeting Access to Kidney Care Via Telehealth: The VA Experience. Advances In Chronic Kidney Disease 2017, 24: 22-30. PMID: 28224939, DOI: 10.1053/j.ackd.2016.11.005.
- Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis.Puthumana J, Ariza X, Belcher JM, Graupera I, Ginès P, Parikh CR. Urine Interleukin 18 and Lipocalin 2 Are Biomarkers of Acute Tubular Necrosis in Patients With Cirrhosis: A Systematic Review and Meta-analysis. Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association 2017, 15: 1003-1013.e3. PMID: 28013112, PMCID: PMC5474196, DOI: 10.1016/j.cgh.2016.11.035.
- A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury.Zhao B, Lu Q, Cheng Y, Belcher JM, Siew ED, Leaf DE, Body SC, Fox AA, Waikar SS, Collard CD, Thiessen-Philbrook H, Ikizler TA, Ware LB, Edelstein CL, Garg AX, Choi M, Schaub JA, Zhao H, Lifton RP, Parikh CR. A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury. American Journal Of Respiratory And Critical Care Medicine 2017, 195: 482-490. PMID: 27576016, PMCID: PMC5378420, DOI: 10.1164/rccm.201603-0518OC.
- Development of a Targeted Urine Proteome Assay for kidney diseases.Cantley LG, Colangelo CM, Stone KL, Chung L, Belcher J, Abbott T, Cantley JL, Williams KR, Parikh CR. Development of a Targeted Urine Proteome Assay for kidney diseases. Proteomics. Clinical Applications 2016, 10: 58-74. PMID: 26220717, PMCID: PMC5003777, DOI: 10.1002/prca.201500020.
- Acute Kidney Injury in Liver Disease: Role of Biomarkers.Belcher JM. Acute Kidney Injury in Liver Disease: Role of Biomarkers. Advances In Chronic Kidney Disease 2015, 22: 368-75. PMID: 26311598, DOI: 10.1053/j.ackd.2015.06.009.
- Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis.Belcher JM, Coca SG, Parikh CR. Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis. PloS One 2015, 10: e0135625. PMID: 26295585, PMCID: PMC4546623, DOI: 10.1371/journal.pone.0135625.
- Urinary biomarkers and progression of AKI in patients with cirrhosis.Belcher JM, Garcia-Tsao G, Sanyal AJ, Thiessen-Philbrook H, Peixoto AJ, Perazella MA, Ansari N, Lim J, Coca SG, Parikh CR. Urinary biomarkers and progression of AKI in patients with cirrhosis. Clinical Journal Of The American Society Of Nephrology : CJASN 2014, 9: 1857-67. PMID: 25183658, PMCID: PMC4220770, DOI: 10.2215/CJN.09430913.
- Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?Belcher JM. Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates? Seminars In Dialysis 2014, 27: 288-91. PMID: 24620917, DOI: 10.1111/sdi.12224.
- Reconsidering a "chopped liver": the need for improving glomular filtration rate estimation for hepatic transplantation.Parikh CR, Belcher JM. Reconsidering a "chopped liver": the need for improving glomular filtration rate estimation for hepatic transplantation. Hepatology (Baltimore, Md.) 2014, 59: 1242-5. PMID: 24470267, DOI: 10.1002/hep.27031.
- Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H, Ansari N, Coca SG, Garcia-Tsao G, Parikh CR. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (Baltimore, Md.) 2014, 60: 622-32. PMID: 24375576, PMCID: PMC4065642, DOI: 10.1002/hep.26980.
- Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury.Belcher JM, Sanyal AJ, Garcia-Tsao G, Ansari N, Coca SG, Shlipak MG, Parikh CR. Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury. International Journal Of Nephrology 2014, 2014: 708585. PMID: 24757564, PMCID: PMC3976933, DOI: 10.1155/2014/708585.
- Acute kidney injury in patients with cirrhosis: perils and promise.Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clinical Gastroenterology And Hepatology : The Official Clinical Practice Journal Of The American Gastroenterological Association 2013, 11: 1550-8. PMID: 23583467, PMCID: PMC3840046, DOI: 10.1016/j.cgh.2013.03.018.
- Association of AKI with mortality and complications in hospitalized patients with cirrhosis.Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, Parikh CR. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (Baltimore, Md.) 2013, 57: 753-62. PMID: 22454364, PMCID: PMC3390443, DOI: 10.1002/hep.25735.
- Is it time to evolve past the prerenal azotemia versus acute tubular necrosis classification?Belcher JM, Parikh CR. Is it time to evolve past the prerenal azotemia versus acute tubular necrosis classification? Clinical Journal Of The American Society Of Nephrology : CJASN 2011, 6: 2332-4. PMID: 21921150, PMCID: PMC3186449, DOI: 10.2215/CJN.08570811.
- Clinical applications of biomarkers for acute kidney injury.Belcher JM, Edelstein CL, Parikh CR. Clinical applications of biomarkers for acute kidney injury. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 2011, 57: 930-40. PMID: 21411200, DOI: 10.1053/j.ajkd.2010.11.032.
- Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study.Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clinical And Translational Gastroenterology 2021, 12: e00359. PMID: 33979307, PMCID: PMC8116001, DOI: 10.14309/ctg.0000000000000359.
- Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward.Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 2022, 79: 737-745. PMID: 34606933, DOI: 10.1053/j.ajkd.2021.08.016.
- The Role of Telenephrology in the Management of CKD.Belcher JM. The Role of Telenephrology in the Management of CKD. Kidney360 2020, 1: 1310-1315. PMID: 35372872, PMCID: PMC8815503, DOI: 10.34067/KID.0000802019.
- Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON.Allegretti AS, Belcher JM. Bile Acids Are Important Contributors to AKI Associated with Liver Disease: CON. Kidney360 2022, 3: 21-24. PMID: 35378020, PMCID: PMC8967622, DOI: 10.34067/KID.0006512020.